BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4268711)

  • 1. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 2. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 3. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
    Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 5. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
    Konaga E
    Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of allograft immunity in tumor-bearing animals by "immune" RNA.
    Rigby PG
    J Lab Clin Med; 1968 May; 71(5):775-83. PubMed ID: 4869636
    [No Abstract]   [Full Text] [Related]  

  • 9. Scanning electron microscopy of contactual interaction of sensitized lymphocytes with homologous target cells.
    Orita K; Yamamoto I; Murakami T
    Acta Med Okayama (1952); 1971 Oct; 25(5):525-36. PubMed ID: 4264431
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance and susceptibility to tumours. V. On the permeation of the 3H thymidine labelled cells from lymphatic organs into the site of proliferating tumour.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):41-62. PubMed ID: 5575434
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
    Nakashima Y
    Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
    Warnatz H
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
    [No Abstract]   [Full Text] [Related]  

  • 14. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the influencing of immunologic reactions by malignant processes].
    Scheurlen PG; Pappas A
    Verh Dtsch Ges Inn Med; 1971; 77():749-52. PubMed ID: 5156058
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the electrophoretic mobility of thymus, spleen and lymph node cells in tumor-bearing mice during dynamic tumor growth].
    Grinevich IuA; Fil'chakov FV; Alekseev SB; Kuz'menko AP
    Tsitologiia; 1989 Feb; 31(2):209-14. PubMed ID: 2734850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro role of thymus-dependent cells in DNA synthesis and LT secretion by PHA-stimulated mouse lymphoid cells.
    Shacks SJ; Chiller J; Granger GA
    Transplant Proc; 1972 Sep; 4(3):303-5. PubMed ID: 5080602
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor inhibition by means of sensitized regional lymph nodes.
    Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
    Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.